Clinical Trial Update: Randomized, Placebo-Controlled Study of Leptin for the Treatment of HIV Lipodystrophy and Metabolic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 randomized, placebo-controlled study evaluating leptin for HIV lipodystrophy and metabolic syndrome; trial completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Lipodystrophy
• Metabolic Syndrome

Drugs mentioned

• Leptin (leptin)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: HAART-induced Lipodystrophy and Metabolic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2017-04-06